» Articles » PMID: 32823684

Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2020 Aug 23
PMID 32823684
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs) have shown their potential as a carrier of molecular information, and they have been involved in physiological functions and diseases caused by viral infections. Virus-infected cells secrete various lipid-bound vesicles, including endosome pathway-derived exosomes and microvesicles/microparticles that are released from the plasma membrane. They are released via a direct outward budding and fission of plasma membrane blebs into the extracellular space to either facilitate virus propagation or regulate the immune responses. Moreover, EVs generated by virus-infected cells can incorporate virulence factors including viral protein and viral genetic material, and thus can resemble noninfectious viruses. Interactions of EVs with recipient cells have been shown to activate signaling pathways that may contribute to a sustained cellular response towards viral infections. EVs, by utilizing a complex set of cargos, can play a regulatory role in viral infection, both by facilitating and suppressing the infection. EV-based antiviral and antiretroviral drug delivery approaches provide an opportunity for targeted drug delivery. In this review, we summarize the literature on EVs, their associated involvement in transmission in viral infections, and potential therapeutic implications.

Citing Articles

Extracellular Vesicles as Biomarkers in Infectious Diseases.

Cruz C, Sodawalla H, Mohanakumar T, Bansal S Biology (Basel). 2025; 14(2).

PMID: 40001950 PMC: 11851951. DOI: 10.3390/biology14020182.


Role of extracellular vesicles in the pathogenesis of mosquito-borne flaviviruses that impact public health.

Martinez-Rojas P, Monroy-Martinez V, Ruiz-Ordaz B J Biomed Sci. 2025; 32(1):4.

PMID: 39754219 PMC: 11699717. DOI: 10.1186/s12929-024-01096-5.


Flow cytometry for extracellular vesicle characterization in COVID-19 and post-acute sequelae of SARS-CoV-2 infection.

Fanelli M, Petrone V, Chirico R, Radu C, Minutolo A, Matteucci C Extracell Vesicles Circ Nucl Acids. 2024; 5(3):417-437.

PMID: 39697632 PMC: 11648478. DOI: 10.20517/evcna.2024.20.


A State-of-the-Art Review on the Recent Advances in Exosomes in Oncogenic Virus.

Ebrahimi F, Modaresi Movahedi A, Sabbaghian M, Poortahmasebi V Health Sci Rep. 2024; 7(11):e70196.

PMID: 39558933 PMC: 11570872. DOI: 10.1002/hsr2.70196.


Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy.

Adugna A, Muche Y, Melkamu A, Jemal M, Belew H, Amare G Heliyon. 2024; 10(14):e34288.

PMID: 39100497 PMC: 11295980. DOI: 10.1016/j.heliyon.2024.e34288.


References
1.
Khatua A, Taylor H, Hildreth J, Popik W . Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J Virol. 2008; 83(2):512-21. PMC: 2612372. DOI: 10.1128/JVI.01658-08. View

2.
Bhatta D, Subedi A, Sharma N . Tobacco smoking and alcohol drinking among HIV infected people using antiretroviral therapy. Tob Induc Dis. 2019; 16:16. PMC: 6659491. DOI: 10.18332/tid/86716. View

3.
Frleta D, Ochoa C, Kramer H, Khan S, Stacey A, Borrow P . HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44. J Clin Invest. 2012; 122(12):4685-97. PMC: 3533550. DOI: 10.1172/JCI64439. View

4.
McNamara R, Dittmer D . Modern Techniques for the Isolation of Extracellular Vesicles and Viruses. J Neuroimmune Pharmacol. 2019; 15(3):459-472. PMC: 7065924. DOI: 10.1007/s11481-019-09874-x. View

5.
DeMarino C, Pleet M, Cowen M, Barclay R, Akpamagbo Y, Erickson J . Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells. Sci Rep. 2018; 8(1):7653. PMC: 5955991. DOI: 10.1038/s41598-018-25943-2. View